This study describes the antibody response to two bacterial antigens, pneumolysin toxoid (PL) and purified pneumococcal capsular polysaccharide (PPS) 19F, in bronchoalveolar lavage (BAL) and in serum in rats after aerosol immunization with whole killed Streptococcus pneumoniae. To study the importance of bacterial adherence for antibody formation, one well-adhering and one poorly adhering strain of S. pneumoniae was used. The results show local specific anti-PPS 19F IgA, IgM and IgG antibody activities after aerosol immunization. Anti-PL antibody activity in all three immunoglobulin classes was found, although the anti-PL activity was lower than the anti-PPS 19F antibody activity. The IgA anti-PPS 19F antibody activity in BAL after immunization with the well-adhering strain was higher than with the poorly adhering strain. We conclude that aerosol immunization with S. pneumoniae induces a local, specific antibody production in the lung of the rat.

Keywords:
Aerosol immunization, Bronchoalveolar lavage, Streptococcus pneumoniae, Antibody response
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.